ASRS
KLRS

Arizona State Retirement System’s Kalaris Therapeutics KLRS Stock Holding History

Arizona State Retirement System’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-632
Closed -$31.3K – 2200
2023
Q3 		$31.3K Buy
632
+175
+38% +$11.9K ﹤0.01% 2165
2023
Q2 		$35.7K Sell
457
-130
-22% -$12.4K ﹤0.01% 2176
2023
Q1 		$53.2K Buy
587
+16
+3% +$2.04K ﹤0.01% 2183
2022
Q4 		$67.4K Buy
571
+22
+4% +$3.73K ﹤0.01% 2164
2022
Q3 		$100K Buy
+549
New +$85.5K ﹤0.01% 2087
2021
Q4 		– Sell
-424
Closed -$244K – 2303
2021
Q3 		$244K Buy
+424
New +$196K ﹤0.01% 1962

Other funds holding KLRS

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Arizona State Retirement System's KLRS Position: Q4 2023 in Review

Arizona State Retirement System sold out of Kalaris Therapeutics (KLRS) in Q4 2023, closing a stake of 632 shares — an estimated $31.3K sold.

Arizona State Retirement System first reported a position in KLRS in Q3 2021 and held it in 6 quarters. The position peaked at $244K in Q3 2021. 81 funds tracked by Wall St. Rank hold KLRS as of Q4 2023.

  • Arizona State Retirement System reported no remaining Kalaris Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 632 Kalaris Therapeutics shares in Q4 2023, an estimated $31.3K.
  • Arizona State Retirement System first reported a position in Kalaris Therapeutics in Q3 2021 and held it in 6 quarters.
  • Arizona State Retirement System's Kalaris Therapeutics position peaked at $244K in Q3 2021.
  • 81 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q4 2023.

Based on Arizona State Retirement System's 13F filing for Q4 2023, filed 24 Jan 2024.